These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9018458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapeutic advances in myositis.
    Aggarwal R, Oddis CV.
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [New therapeutic approaches for polymyositis and dermatomyositis].
    Dankó K, Vincze M.
    Orv Hetil; 2011 Sep 25; 152(39):1552-9. PubMed ID: 21920841
    [Abstract] [Full Text] [Related]

  • 5. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH, Hoogendijk JE, Lecky B, Winer JB.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD003643. PubMed ID: 16034905
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
    Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC.
    Arthritis Res Ther; 2012 Jan 27; 14(1):R22. PubMed ID: 22284862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A.
    Rev Med Interne; 2014 Jul 27; 35(7):466-71. PubMed ID: 24144868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Use of methotrexate in inflammatory myopathies.
    Fendler C, Braun J.
    Clin Exp Rheumatol; 2010 Jul 27; 28(5 Suppl 61):S164-7. PubMed ID: 21044453
    [Abstract] [Full Text] [Related]

  • 14. Treatment of refractory polymyositis and dermatomyositis.
    Ytterberg SR.
    Curr Rheumatol Rep; 2006 Jun 27; 8(3):167-73. PubMed ID: 16901073
    [Abstract] [Full Text] [Related]

  • 15. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG, Katz JD, Jones OY.
    Rheum Dis Clin North Am; 2013 Nov 27; 39(4):877-904. PubMed ID: 24182859
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppressive drug therapy.
    McCune WJ, Vallance DK, Lynch JP.
    Curr Opin Rheumatol; 1994 May 27; 6(3):262-72. PubMed ID: 8060760
    [Abstract] [Full Text] [Related]

  • 17. Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study.
    Keyßer G, Zierz S, Kornhuber M.
    Z Rheumatol; 2019 Mar 27; 78(2):183-189. PubMed ID: 29713867
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
    Vermaak E, Tansley SL, McHugh NJ.
    Clin Rheumatol; 2015 Dec 27; 34(12):2089-95. PubMed ID: 26299472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.